Clinical and molecular insights into lymphangioleiomyomatosis.

Clinical and molecular insights into lymphangioleiomyomatosis.

Item
http://www.wikidata.org/entity/Q36386236
Isoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic DiseaseComputer-Aided Grading of Lymphangioleiomyomatosis (LAM) using HRCTChemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene.Acral lesions in tuberous sclerosis complex: insights into pathogenesisOral findings in 58 adults with tuberous sclerosis complexErythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosisPrimary abdominal lymphangioleiomyomatosis: report of a case.Potential Applications of Using 68Ga-Evans Blue PET/CT in the Evaluation of Lymphatic Disorder: Preliminary Observations.Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene
P2860

Clinical and molecular insights into lymphangioleiomyomatosis.

Item
http://www.wikidata.org/entity/Q36386236
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Clinical and molecular insights into lymphangioleiomyomatosis.
@ast
Clinical and molecular insights into lymphangioleiomyomatosis.
@en
type
label
Clinical and molecular insights into lymphangioleiomyomatosis.
@ast
Clinical and molecular insights into lymphangioleiomyomatosis.
@en
prefLabel
Clinical and molecular insights into lymphangioleiomyomatosis.
@ast
Clinical and molecular insights into lymphangioleiomyomatosis.
@en
P1433
P1476
P2093
P304
P31
P478
P577
P698
P1433
P1476
Clinical and molecular insights into lymphangioleiomyomatosis
@en
P2093
P304
P31
P478
P577
P698